TABLE 4.
Antimicrobial resistance of Shigella species isolates from children with acute diarrhea in Tehran, Iran
| Shigella serotype |
Resistance, n (%) |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ERY | CEF | CFM | CRO | TET | AMP | CAZ | SXT | NAL | AMC | GEN | CHL | CIP | SAM | |
| S sonnei | 66 (75) | 26 (29.5) | 1 (1.1) | 0 | 85 (96.5) | 50 (56.8) | 0 | 85 (96.5) | 2 (2.3) | 27 (30.6) | 0 | 8 (9) | 0 | 1 (1.2) |
| S flexneri | 29 (60) | 4 (8.3) | 0 | 0 | 46 (95.8) | 23 (47.9) | 0 | 42 (87.5) | 0 | 26 (54.1) | 2 (4.0) | 23 (47.9) | 0 | 0 |
| S boydii | 11 (84) | 6 (38.4) | 0 | 0 | 11 (84.6) | 5 (38.4) | 0 | 10 (76.9) | 2 (15.4) | 8 (61.5) | 0 | 1 (7.6) | 0 | 0 |
| S dysenteriae | 6 (75) | 1 (12.5) | 0 | 0 | 8 (100) | 3 (37.5) | 0 | 7 (87.5) | 0 | 1 (12.5) | 0 | 0 | 0 | 0 |
AMC Amoxicillin-clavulanic acid; AMP Ampicillin; CAZ Ceftazidime; CEF Cephalothin; CFM Cefixime; CHL Chloramphenicol; CIP Ciprofloxacin; CRO Ceftriaxone; ERY Erythromycin; GEN Gentamicin; NAL Nalidixic acid; SAM Ampicillin-sulbactam; SXT Trimethoprim-sulfamethoxazole; TET Tetracycline